Press "Enter" to skip to content

New patent for Zogenix Inc drug FINTEPLA

0
Copyright © DrugPatentWatch. Originally published at New patent for Zogenix Inc drug FINTEPLA

Annual Drug Patent Expirations for FINTEPLA
Annual Drug Patent Expirations for FINTEPLA

Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has seventy-two patent family members in twenty-five countries.

The generic ingredient in FINTEPLA is fenfluramine hydrochloride. One supplier is listed for this compound. Additional details are available on the fenfluramine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Zogenix Inc drug FINTEPLA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions